STAT Plus Bluebird Bio reported a diagnosis of myelodysplastic syndrome in a single sickle cell disease patient who had undergone treatment with the biotechs Lentiglobin gene therapy. httpsbuff.ly2Suit7FÂ

STAT Plus: Bluebird Bio reported a diagnosis of myelodysplastic syndrome in a single sickle cell disease patient who had undergone treatment with the #biotech’s Lentiglobin gene therapy. https://buff.ly/2Suit7F 

STAT Plus: Bluebird Bio reported a diagnosis of myelodysplastic syndrome in a single sickle cell disease patient who had undergone treatment with the #biotech’s Lentiglobin gene therapy. https://buff.ly/2Suit7F 

More From BioPortfolio on "STAT Plus: Bluebird Bio reported a diagnosis of myelodysplastic syndrome in a single sickle cell disease patient who had undergone treatment with the #biotech’s Lentiglobin gene therapy. https://buff.ly/2Suit7F "